Given the importance of ER in breast cancer and considering the differential effect of EB1089 on ERα expression in ER-positive and ER-negative breast cancer cells (as depicted in Figure 1), we investigated the effect of treatments on ERα protein expression in BT-474 and SK-BR-3 cells. This evidence concerns the gene ESR1 and breast cancer.